Key facts
- Notable investors include Khosla Ventures, FORM Life Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Vero (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Vero (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vero (Biotechnology)
Developer of a proteomics platform designed to simplify complex analytics to accelerate biological discoveries. The company's platform facilitates pioneering proteomics for precision organ health, enabling users to interpret complex biological data in a way that is understandable for researchers and scientists.
- Sector
- Healthcare
- HQ
- San Francisco Bay Area, CA, United States
- Founded
- 2024
- Website
- verobioscience.com/
- Ownership
- Privately Held (backing)
Vero (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vero (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vero (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.